Ismail-Sutton, S., Hughes, B., Buchwald, Z. S., Wreglesworth, N. I., Dallmann, R., Innominato, P. F.

Emerging evidence highlights the critical role of time-of-day (ToD) in immunotherapy, with large-scale retrospective studies showing that administering immune checkpoint inhibitors (ICIs) earlier in the day is associated with significantly improved ef…